医学
结直肠癌
细胞毒性T细胞
CD8型
免疫系统
阶段(地层学)
肿瘤科
组织微阵列
内科学
免疫组织化学
癌症
胃肠病学
病理
癌症研究
免疫学
生物
古生物学
体外
生物化学
作者
Franck Pagès,Amos Kirilovsky,Bernhard Mlecnik,Martin Asslaber,Marie Tosolini,Gabriela Bindea,Christine Lagorce,Philippe Wind,Florence Marliot,Patrick Bruneval,Kurt Zatloukal,Zlatko Trajanoski,Anne Berger,Wolf H. Fridman,Jérôme Galon
标识
DOI:10.1200/jco.2008.19.6147
摘要
Purpose Many patients who present with early-stage colorectal cancer (International Union Against Cancer TNM stages I and II) are nevertheless at high risk of relapse. We hypothesized that intratumoral immune reaction could influence their prognosis. Patients and Methods The intratumoral immune reaction was investigated in 29 tumors by large-scale real-time polymerase chain reaction. Cytotoxic (CD8) and memory (CD45RO) T cells were quantified by immunohistochemical analyses of tissue microarrays from the center (CT) and the invasive margin (IM) of the 602 tumors from two independent cohorts. The results were correlated with tumor recurrence and patient survival. Results Patients with a strong infiltration of CD45RO + cells in the tumor exhibited an increased expression of T-helper 1 and cytotoxicity-related genes. Densities of CD45RO + and CD8 + cells in tumor regions (CT/IM) classified the patients into four distinct prognostic groups based on the presence of high density of each marker in each tumor region. The four groups were associated with dramatic differences in disease-free, disease-specific, and overall survival (all P < .0001). Five years after diagnosis, only 4.8% (95% CI, 0.6% to 8.8%) of patients with high densities of CD8 + plus CD45RO + cells had tumor recurrence, and 86.2% (CI, 79.4% to 93.6%) survived. In contrast, the tumor recurred in 75% (95% CI, 17% to 92.5%) of patients with low densities of these cells, and only 27.5% (95% CI, 10.5% to 72%) survived (all P < .0001). Multivariate analyses showed that the immune criteria had independent effects on the rates of complete remission and survival. Conclusion The combined analysis of CD8 + plus CD45RO + cells in specific tumor regions could provide a useful criterion for the prediction of tumor recurrence and survival in patients with early-stage colorectal cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI